$ABBV has been discussed by 7 distinct FinTwit voices across 45 mentions over the past 12 months, with the first mention appearing on August 25, 2025. The biotech-focused voices have dominated discussion of AbbVie, with @jacobplieth contributing 36 mentions—the vast majority of the total conversation. @adamfeuerstein is the second most active voice with 11 mentions, followed by @tradableastro with 2 mentions, while @alphaticaio, and @jasonl_capital each contributed 1 mention. The most recent activity centers on AbbVie's acquisition activity in the therapeutics space.